Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 3.080
-0.040 (-1.28%)
Oct 26, 2026, 5:43 PM CET
Biofrontera AG Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 15.97 | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 |
Revenue Growth | 42.05% | 8.26% | -62.22% | 25.29% | -10.59% | -5.14% |
Gross Profit Gross Profit Growth | 12.94 | 10.91 | 10.12 | 26.01 | 20.98 | 24.87 |
Operating Income Operating Income Growth | 1.8 | -1.03 | -1.59 | 4.78 | 1.59 | -15.88 |
Net Income Net Income Growth | 5.26 | -3.97 | -4.35 | -0.37 | -44.17 | 38.32 |
Earnings Per Share EPS Growth | 0.86 | -0.65 | -0.72 | -0.21 | -16.17 | 14.28 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Germany Germany Growth | 12.27 | 9.86 | 7.83 | 6.26 | 4.76 | 5.26 |
Spain Spain Growth | 1.66 | 1.73 | 1.7 | 1.74 | 1.76 | - |
UK UK Growth | 1.22 | 0.98 | 0.84 | 0.72 | 0.66 | - |
Rest of Europe Rest of Europe Growth | 0.81 | 0.61 | 1.7 | 1.2 | 1.08 | - |
Other Regions Other Regions Growth | 0.01 | 0.01 | 0.12 | 0.11 | 0.34 | - |
Total Total Growth | 15.97 | 13.19 | 12.18 | 32.25 | 25.74 | 28.79 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.11 | 3.6 | 3.12 | 3.08 | 6.38 | 6.91 |
Total Debt Total Debt Growth | 1.63 | 0.07 | 0.77 | 1.15 | 1.5 | 3.3 |
Net Cash (Debt) Net Cash Growth | 5.48 | 3.54 | 2.36 | 1.93 | 4.88 | 3.61 |
Net Cash Growth | - | 49.98% | 21.98% | -60.33% | 35.12% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.90 | 0.58 | 0.39 | 0.64 | 1.78 | 1.34 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | -4.4 | -2.54 | -1.91 | -3.9 | 30.44 |
Capital Expenditures CapEx Growth | - | -0.05 | -0.21 | -0.91 | -0.98 | -0.63 |
Free Cash Flow Free Cash Flow Growth | - | -4.45 | -2.75 | -2.82 | -4.88 | 29.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 81.06% | 82.71% | 83.03% | 80.64% | 81.52% | 86.41% |
Operating Margin | 11.29% | -7.77% | -13.03% | 14.83% | 6.18% | -55.17% |
Pretax Margin | 9.99% | -9.27% | -9.45% | -6.60% | -167.88% | 123.96% |
Profit Margin | 32.95% | -30.06% | -35.70% | -1.14% | -171.60% | 133.11% |
FCF Margin | - | -33.75% | -22.56% | -8.73% | -18.95% | 103.55% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.57 | - | - | - | - | 2.19 |
Forward PE | - | 17.72 | 17.72 | 17.72 | 104.00 | - |
P/FCF Ratio | - | - | - | - | - | 2.82 |
PS Ratio | 1.19 | 1.12 | 1.07 | 0.79 | 3.78 | 2.92 |